Clinical Pearl: Korsuva (Difelikefalin)

Authors

DOI:

https://doi.org/10.64945/cvttgz97

Keywords:

Difelikefalin, CKD-associated pruritus, Haemodialysis, Antipruritic therapy

Author Biography

  • Associate Professor Ronald Castelino, University of Sydney

    Associate Professor and Head of Pharmacy Practice & Health Services Research at the School of Pharmacy, University of Sydney

Downloads

Published

31.08.2026 — Updated on 07.09.2026

Versions

Issue

Vol. 1 No. 2 (2026)

Section

Nephro Visual Pearls

License

Copyright (c) 2026 Jing Xin Goh, Associate Professor Ronald Castelino (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0), which permits non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited, and any derived works are licensed under the same terms.

The copyright remains with the author(s). The authors grant Australasian Journal of Clinical Nephrology the non-exclusive right to publish and distribute the article.

To view a copy of this license, visit: https://creativecommons.org/licenses/by-nc-sa/4.0/

 

How to Cite

Clinical Pearl: Korsuva (Difelikefalin). (2026). Australasian Journal of Clinical Nephrology, 1(2). https://doi.org/10.64945/cvttgz97 (Original work published 2026)